The upregulation of KDM2A contributed to regulatory T-cell proliferation and immune tolerance in glioma samples and a tumor xenograft mouse model as it demethylated the jagged 1 (JAG1) promoter region, elevating JAG1 expression and contributing to regulatory T-cell proliferation. This evidence concerns the gene KDM2A and central nervous system cancer.